OBJECTIVE—
The Type 1 Diabetes Genetics Consortium (T1DGC) has assembled and genotyped a large collection of multiplex families for the purpose of mapping genomic regions linked to type 1 diabetes. In the current study, we tested for evidence of loci associated with type 1 diabetes utilizing genome-wide linkage scan data and family-based association methods.
RESEARCH DESIGN AND METHODS—
A total of 2,496 multiplex families with type 1 diabetes were genotyped with a panel of 6,090 single nucleotide polymorphisms (SNPs). Evidence of association to disease was evaluated by the pedigree disequilibrium test. Significant results were followed up by genotyping and analyses in two independent sets of samples: 2,214 parent-affected child trio families and a panel of 7,721 case and 9,679 control subjects.
RESULTS—
Three of the SNPs most strongly associated with type 1 diabetes localized to previously identified type 1 diabetes risk loci:
INS
,
IFIH1
, and
KIAA0350
. A fourth strongly associated SNP, rs876498 (
P
= 1.0 × 10
−4
), occurred in the sixth intron of the
UBASH3A
locus at chromosome 21q22.3. Support for this disease association was obtained in two additional independent sample sets: families with type 1 diabetes (odds ratio [OR] 1.06 [95% CI 1.00–1.11];
P
= 0.023) and case and control subjects (1.14 [1.09–1.19];
P
= 7.5 × 10
−8
).
CONCLUSIONS—
The T1DGC 6K SNP scan and follow-up studies reported here confirm previously reported type 1 diabetes associations at
INS
,
IFIH1
, and
KIAA0350
and identify an additional disease association on chromosome 21q22.3 in the
UBASH3A
locus (OR 1.10 [95% CI 1.07–1.13];
P
= 4.4 × 10
−12
). This gene and its flanking regions are now validated targets for further resequencing, genotyping, and functional studies in type 1 diabetes.